WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults—Reply
JAMA · 28.04.2026 · 335 (16) · 1451
DOI: 10.1001/jama.2026.0687 ↗Kurz gefasst
Leitlinie in der Zeitschrift JAMA, erschienen am 28.04.2026. Verfasst von Francesca Celletti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: World Health Organization.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland.
- Health Promotion, Prevention, and Care, World Health Organization, Geneva, Switzerland.
Förderung
- World Health Organization
Zitieren
APA
Celletti, F., Farrar, J., & De Regil, L. (2026). WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults—Reply. JAMA, 335(16), 1451. https://doi.org/10.1001/jama.2026.0687
Vancouver
Celletti F, Farrar J, De Regil L. WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults—Reply. JAMA. 2026;335(16):1451. doi:10.1001/jama.2026.0687
BibTeX
@article{Celletti2026,
author = {Celletti, Francesca and Farrar, Jeremy and De Regil, Luz},
title = {WHO Guideline on GLP-1 Therapies for Treatment of Obesity in Adults—Reply},
journal = {JAMA},
year = {2026},
volume = {335},
number = {16},
pages = {1451},
doi = {10.1001/jama.2026.0687}
}
EUVIMED